Browsing by Author "Breder, V."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemHealth-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma : KEYNOTE-240(2021) Ryoo, B. Y.; Merle, P.; Kulkarni, A. S.; Cheng, A. L.; Bouattour, M.; Lim, H. Y.; Breder, V.; Edeline, J.; Chao, Y.; Garrido S., Marcelo; Ogasawara, S.; Yau, T.; Chan, S. L.; Daniele, B.; Norquist, J. M.; Chen, E.; Siegel, A. B.; Zhu, A. X.; Finn, R. S.; Kudo, M.
- ItemPembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial(2020) Finn, R.S.; Ryoo, B.Y.; Merle, P.; Bouattour, M.; Lim, H.Y.; Breder, V.; Edeline, J.; Chao, Y.; Ogasawara, S.; Yau, T.; Garrido, M.; Chan, S.L.; Knox, J.; Daniele, B.; Ebbinghaus, S.W.; Chen, E.; Siegel, A.B.; Zhu, A.X.; Cheng, A.L.